Skip to content

    Autolus Therapeutics (AUTL) stock price & financials

    View AUTL earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+49.0% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $0
    $29.0K
    $8.98M
    $20.92M
    $21.19M
    $24.29M
    +83655.2%
    $26.22M
    +191.9%
    $45.69M
    +118.4%
    Strengthening
    Operating Profit
    -$67.88M
    -$75.86M
    -$65.24M
    -$61.22M
    -$71.62M
    -5.5%
    -$72.47M
    +4.5%
    -$59.51M
    +8.8%
    -$43.84M
    +28.4%
    Strengthening
    Net Profit
    -$82.09M
    -$27.61M
    -$70.16M
    -$47.92M
    -$79.12M
    +3.6%
    -$90.33M
    -227.2%
    -$71.60M
    -2.0%
    -$39.11M
    +18.4%
    Weakening
    EPS
    $-0.31
    $-0.26
    $-0.18
    $-0.30
    +3.2%
    $-0.27
    -3.8%
    $-0.15
    +16.7%
    Strengthening
    Other Income
    -$14.20M
    $49.72M
    -$2.70M
    $13.70M
    -$6.96M
    +50.9%
    -$19.05M
    -138.3%
    -$11.22M
    -316.2%
    $5.19M
    -62.1%
    Weakening
    Interest
    $10.69M
    -$30.84M
    $10.14M
    -$6.83M
    $10.52M
    -1.6%
    $22.84M
    $11.12M
    +9.7%
    -$2.67M
    +60.8%
    Strengthening
    Depreciation
    Profit before Tax
    -$82.07M
    -$26.14M
    -$67.94M
    -$47.52M
    -$78.59M
    +4.2%
    -$91.51M
    -250.1%
    -$70.73M
    -4.1%
    -$38.65M
    +18.7%
    Weakening
    MarginsOPM
    -261600.0%
    -726.3%
    -292.6%
    -337.9%
    -298.4%
    +99.9%
    -227.0%
    +68.7%
    -96.0%
    +67.2%
    Strengthening
    Tax
    -0.0%
    -5.6%
    -3.3%
    -0.8%
    -0.7%
    -2166.7%
    1.3%
    -1.2%
    +62.8%
    -1.2%
    -42.9%
    Strengthening
    ReturnsROIC
    5.5%
    1.8%
    4.7%
    3.2%
    5.3%
    -3.6%
    6.0%
    +227.2%
    4.8%
    +2.0%
    2.6%
    -18.4%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$246.98M$210.64M$153.30M$310.34M$382.44M$239.57M$227.38M$104.13M$171.41M
    Short-Term Investments
    Total Current Assets$259.28M$249.26M$196.98M$346.95M$425.77M$275.30M$660.93M$435.92M$336.09M
    Net PP&E$13.53M$51.57M$89.68M$52.32M$58.42M$95.65M$105.05M$128.50M$134.63M
    Goodwill
    Intangibles$399.0K$254.0K$158.0K$65.0K$0$0$12.37M$19.81M$18.53M
    Total Assets$273.20M$303.53M$294.24M$405.56M$490.27M$375.38M$782.73M$589.07M$493.23M
    LiabilitiesTotal Current Liabilities$17.14M$24.98M$33.63M$28.55M$46.37M$44.74M$60.74M$73.44M$68.79M
    Short-Term Debt
    Long-Term Debt$380.0K$0
    Long-Term Leases$23.71M$50.57M$16.55M$19.22M$47.91M$49.63M$66.82M$77.72M
    Total Liabilities$17.74M$48.69M$84.20M$92.24M$191.60M$263.91M$355.40M$410.94M$418.39M
    EquityCommon Stock & APIC
    Retained Earnings-$92.65M-$237.15M-$379.24M-$521.34M-$670.18M-$878.56M-$1.10B-$1.39B-$1.50B
    Total Equity$255.47M$254.84M$210.03M$313.32M$298.67M$111.47M$427.32M$178.13M$74.84M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$31.54M-$101.48M-$117.76M-$117.86M-$112.31M-$145.59M-$206.27M-$283.57M-$225.61M
    Cash from Investing-$9.53M-$18.67M-$14.68M-$8.86M-$10.84M-$10.99M-$394.55M$158.46M$286.14M
    Cash from Financing$156.92M$108.86M$74.42M$284.06M$223.61M-$883.0K$589.55M-$4.34M-$7.77M
    SummaryCapital Expenditure-$9.12M-$18.34M-$14.68M-$8.86M-$10.84M-$10.99M-$22.07M-$19.04M-$7.12M
    Free Cash Flow-$40.66M-$119.83M-$132.44M-$126.72M-$123.15M-$156.57M-$228.35M-$302.61M-$232.73M
    FCF Margin-2889.6%-4120.5%-9221.0%-2256.4%-401.4%-198.3%

    Ratios